Live from the NIH registry
Studies recruiting near Winston-Salem right now
Top 25 of 590 recruiting studies, sorted by proximity — each links to its official registry page
Collection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid Tumors
Unspecified Adult Solid Tumor, Protocol Specific, Unspecified Childhood Solid Tumor, Protocol Specific
N/A
Observational 20,000 participants sought
Wake Forest University Comprehensive Cancer Center — Winston-Salem, North Carolina (1.0 mi)
· Sponsor: Wake Forest University Health Sciences
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Novant Health Forsyth Medical Center — Winston-Salem, North Carolina (1.0 mi)
· Sponsor: SWOG Cancer Research Network
Open Versus Arthroscopic Stabilization of Shoulder Instability With Subcritical Bone Loss: The OASIS Trial
Shoulder Dislocation, Glenohumeral Dislocation
N/A
Observational 450 participants sought
Wake Forest University — Winston-Salem, North Carolina (1.0 mi)
· Sponsor: University of Pittsburgh
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Wake Forest University Health Sciences — Winston-Salem, North Carolina (1.0 mi)
· Sponsor: National Cancer Institute (NCI)
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
Chronic Kidney Disease
Phase 2
Interventional 465 participants sought
Brookview Hills Research Associates, LLC — Winston-Salem, North Carolina (1.0 mi)
· Sponsor: Novo Nordisk A/S
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Lymphoma, Large B-Cell, Diffuse
Phase 2
Interventional 594 participants sought
Novant Health Forsyth Medical Center ( Site 0206) — Winston-Salem, North Carolina (1.0 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
Non-Small Cell Lung Cancer (NSCLC)
Phase 3
Interventional 750 participants sought
Novant Health Pharmacy Oncology Specialists — Winston-Salem, North Carolina (1.0 mi)
· Sponsor: Bristol-Myers Squibb
HDClarity: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Development for Huntington's Disease
Huntington's Disease
N/A
Observational 2,500 participants sought
Wake Forest University — Winston-Salem, North Carolina (1.0 mi)
· Sponsor: University College, London
BE WELL With Migraine: Brain Education and WELLness With Migraine
Migraine
N/A
Interventional 286 participants sought
Wake Forest University Health Sciences — Winston-Salem, North Carolina (1.0 mi)
· Sponsor: Wake Forest University Health Sciences
Evaluation of the Pathobiology of CALR-mutated MPN Cells
Myeloproliferative Neoplasm
N/A
Observational 35 participants sought
Wake Forest Baptist Comprehensive Cancer Center — Winston-Salem, North Carolina (1.0 mi)
· Sponsor: Wake Forest University Health Sciences
Telehealth Intervention for Improving Distress and Financial Toxicity in the Caregivers
Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm
N/A
Interventional 50 participants sought
Wake Forest Baptist Comprehensive Cancer Center — Winston-Salem, North Carolina (1.0 mi)
· Sponsor: Wake Forest University Health Sciences
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
Chronic Migraine
Phase 3
Interventional 420 participants sought
Headache Wellness Center /ID# 270568 — Greensboro, North Carolina (26.3 mi)
· Sponsor: AbbVie
Clinical Study of a Vaginal Cooling Device for the Treatment of Vulvovaginal Candidiasis (VVC)
Vulvovaginal Candidiasis (VVC), Yeast Vaginitis
N/A
Interventional 55 participants sought
Lyndhurst Clinical Research — Winston-Salem, North Carolina (1.0 mi)
· Sponsor: Coologics, Inc
Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)
Complex Regional Pain Syndrome Type I
Phase 3
Interventional 270 participants sought
Ambros Clinical Trial Site — Winston-Salem, North Carolina (1.0 mi)
· Sponsor: Ambros Therapeutics, Inc.
Comparative Self-collection for Cervical Cancer Screening Pivotal Study
HPV, HPV - Anogenital Human Papilloma Virus Infection
N/A
Interventional 260 participants sought
Lyndhurst Clinical Research (Unified) — Winston-Salem, North Carolina (1.0 mi)
· Sponsor: Mel Mont Medical
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
Neuroblastoma
Phase 2
Interventional 93 participants sought
Wake Forest University Health Sciences — Winston-Salem, North Carolina (1.0 mi)
· Sponsor: Giselle Sholler
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
Locally Advanced Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 1,145 participants sought
Research Site — Winston-Salem, North Carolina (1.0 mi)
· Sponsor: AstraZeneca
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
Cone Health Cancer Center — Greensboro, North Carolina (26.3 mi)
· Sponsor: NRG Oncology
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
Atherosclerotic Cardiovascular Disease (ASCVD)
Phase 3
Interventional 340 participants sought
Wake Forest University Baptist Medical Center — Winston-Salem, North Carolina (1.0 mi)
· Sponsor: Novartis Pharmaceuticals
ONC-LEUK-2406: The Impact of Systematic Financial Navigation in Acute Myeloid Leukemia
Acute Myeloid Leukemia
N/A
Interventional 120 participants sought
Atrium Health Wake Forest Baptist Comprehensive Cancer Center — Winston-Salem, North Carolina (1.0 mi)
· Sponsor: Wake Forest University Health Sciences
Optimizing the AYA Survivors' Coping and Emotional Needs Toolkit
Depression, Cancer
N/A
Interventional 208 participants sought
Wake Forest University — Winston-Salem, North Carolina (1.0 mi)
· Sponsor: East Carolina University
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
Large B-cell Lymphoma, Lymphoma, B-Cell
Phase 3
Interventional 400 participants sought
Atrium Health Wake Forest Baptist Comprehensive Cancer Center — Winston-Salem, North Carolina (1.0 mi)
· Sponsor: Lyell Immunopharma, Inc.
A Clinical Study to Evaluate the Efficacy and SPF of Two Test Materials According to an Adaptation of the Guidelines of the FDA Sunscreen Drug Products for Over-the-Counter Human Use
Epidermis, Ultraviolet Exposure
Phase 4
Interventional 60 participants sought
Eurofins | CRL, Cosmetics LLC — Winston-Salem, North Carolina (1.0 mi)
· Sponsor: Good Molecules, LLC
Generate and Test the Reliability of a PD Model of OXT on Pupillary Hippus as a Measure of CNS Activity
Chronic Pain, Osteoarthritis, Knee
Phase 2
Interventional 38 participants sought
Wake Forest Baptist Health — Winston-Salem, North Carolina (1.0 mi)
· Sponsor: Wake Forest University Health Sciences
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
Diffuse Large B-Cell Lymphoma, Grade 3b Follicular Lymphoma
Phase 2
Interventional 396 participants sought
Wake Forest University Health Sciences — Winston-Salem, North Carolina (1.0 mi)
· Sponsor: SWOG Cancer Research Network